Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging beyond the menopausal transition.
|Articles|August 18, 2006
Myomectomy, Fibroids and Fertility Video
Author(s)Tamer A. Seckin, MD
From the 35th Annual Meeting - Las Vegas, Nevada- November 2006
Advertisement
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of Windows Media Player, available
Advertisement
Related to this article
A global consensus published in The Lancet has officially renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a change with broad implications for diagnosis, care, and cardiometabolic screening.
The Preeclampsia Foundation released 2 videos on postpartum recovery and long-term health after HDP.
AJOG research shows a cytokine storm could be detectable in maternal blood before the clinical onset of AFE.
CDC data show gestational hypertension rose 73% from 2016 to 2024, affecting 1 in 10 US mothers giving birth.
Missed the updated IDSA histoplasmosis guideline? This easy-to-read FAQ covers what clinicians caring for pregnant patients need to know.
The FDA accepted an sNDA and granted priority review for elinzanetant to treat VMS in women receiving endocrine therapy to treat or prevent HR+ breast cancer.
In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Gestational hypertension rose 73% from 2016 to 2024, CDC data show
2
Preeclampsia Foundation launches postpartum recovery videos for HDP
3
FAQ: What does the rename from PCOS to PMOS mean for your patients?
4
Cytokine storm detected before AFE symptoms in AJOG case report
5